Pepteca.
<- Peptides for cats

BPC-157 · Cats

BPC-157 for cats

Last reviewed 2026-08-28 · 5 sources

The direct answer

People give cats BPC-157 by borrowing dog protocols, but cats are the highest-caution species for it. There are no feline studies, and cats process many drugs differently from dogs and people, so dog-derived doses rest on an assumption that often fails in cats. It is not an approved product, and the cancer caution applies as it does everywhere.

Why a cat is not a small dog

The reasoning behind pet-peptide dosing is simple: take a dose, scale it to body weight, adjust. That works only if the animal processes the compound roughly the way the source animal does. Cats break that assumption. Their livers lack some of the enzyme pathways that dogs and humans use to clear certain drugs, which is the well-known reason a number of medicines and even common supplements that are safe for dogs are toxic to cats. Nobody has tested where BPC-157 falls, so the safe reading is that a dog dose scaled to a cat is not a cautious estimate - it is an untested guess in the animal least forgiving of guesses.

There is no feline evidence at all

For dogs, there is at least pharmacokinetic data and a deep rodent literature to argue from. For cats there is neither. The healing studies are in rats; the handling data is in dogs; the cat column is empty. So any confident claim about BPC-157 in cats - a dose, a benefit, a safety margin - is built on nothing feline-specific. Honest sourcing here means saying that plainly rather than dressing up a dog number as a cat number.

What owners hope it does, and the better first step

Cat owners reach for BPC-157 for wound and soft-tissue healing, gut problems like IBD, and condition in older cats. Several of those overlap with serious, diagnosable senior-cat diseases - chronic kidney disease, hyperthyroidism, dental pain, cancer - and cats hide illness well. The highest-value move for a cat that seems off is a veterinary workup, not a general repair peptide, because the peptide can delay a diagnosis that changes everything. The cancer caution (BPC-157 grows blood vessels, tumors need them) applies to cats too.

For the cross-species safety and legality picture, see are peptides safe for pets?

Questions people ask

Can you give a cat BPC-157?

People do, usually by copying dog protocols and scaling down for weight, but cats are the species where that reasoning is least safe. There are no feline studies on BPC-157, and cats process many drugs differently from dogs and people. So a cat dose is an assumption stacked on an assumption, with no cat-specific evidence underneath it.

How much BPC-157 for a cat?

There is no established dose, and no feline data to derive one from. The figures people cite are borrowed from dog protocols and scaled by body weight, which quietly assumes a cat handles the compound the same way a dog does - the exact assumption that fails most often in cats. Any specific cat number should be treated as a guess, not a protocol.

Is BPC-157 dangerous for cats specifically?

Nobody has tested it, so the honest answer is that the risk is unknown and unusually hard to predict. Cats lack some of the enzyme machinery other species use to clear drugs, which is why several substances safe for dogs are dangerous for cats. That does not prove BPC-157 is harmful to cats - it means the usual safety extrapolation does not apply, and the cancer caution (it grows blood vessels) applies as it does in any species.

Keep reading

Sources

No feline BPC-157 research exists to cite - that absence is the point. The sources below are the mechanistic and carnivore data people extrapolate from, plus the cancer and regulatory context. Full compound sourcing is on the BPC-157 library card.

  1. [1]Multifunctionality and Possible Medical Application of the BPC 157 Peptide - Literature and Patent ReviewreviewReviews the animal-model evidence that BPC-157 accelerates healing of tendon, ligament, muscle and gut tissue, and that it promotes new blood vessel growth (angiogenesis) - the same mechanism behind the caution in animals with cancer. Almost all of this work is in rodents. Accessed 2026-08-28.
  2. [2]Pharmacokinetics, distribution, metabolism, and excretion of BPC 157 in rats and dogsstudyBPC-157's absorption and clearance were characterized in dogs among other species - one of the few pieces of canine-specific data that exists for the compound, and pharmacokinetic, not efficacy. Accessed 2026-08-28.
  3. [3]Cancer in pets (American Veterinary Medical Association)referenceThe AVMA states roughly 1 in 4 dogs will develop cancer at some point, rising to about 1 in 2 for dogs 10 years and older. Accessed 2026-08-28.
  4. [4]CVM GFI #256: Compounding Animal Drugs from Bulk Drug Substances (FDA)regulatoryFDA's guidance describing the narrow conditions under which it will not act against animal drugs compounded from bulk substances - for non-food animals, by or on the order of a licensed veterinarian, when no approved option works. A research peptide bought online and injected without a vet is outside this. Accessed 2026-08-28.
  5. [5]Q&A: GFI #256 Compounding Animal Drugs from Bulk Drug Substances (FDA)regulatoryFDA's plain-language Q&A confirming that drugs compounded from bulk substances are not FDA-approved and do not meet approval, manufacturing or labeling requirements. Accessed 2026-08-28.

Pepteca is for education and information only. It does not provide medical advice, diagnosis, or treatment, and its calculators perform unit math only. Always verify with a licensed provider before starting, changing, or stopping any protocol. Many peptides are not approved for human use and may be regulated differently where you live.

Be first to the tracker.

We are building a private tracker for the protocols this library documents - dose logs, a vial inventory that actually deducts, and reminders. Join the waitlist and we will email you when it opens. Email only, no spam, unsubscribe anytime.